Study for the pathogenesis of osteoporosis in diabetic foot

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024401

Enrollment

Unknown

Registered

2019-07-10

Start date

2019-07-08

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot and osteoporosis

Interventions

healthy control group:N/A

simple diabetes group:N/A

diabetic foot group, was divided into normal bone mass and abnormal group according to bone mineral density (including bone loss and osteoporosis).:N/A

Eligibility

Sex/Gender

All

Age

20 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Aged 20-80 years; (2) Meets WHO Diabetes and Diabetes Foot Diagnostic Criteria and reaches Wagner Grade 2 or above (including Level 2).

Exclusion criteria

Exclusion criteria: (1) Combined with hyperthyroidism, parathyroidism, adrenal hyperfunction, hyperprolactinemia, acromegaly. (2) Patients with severe liver and kidney dysfunction. (3) Patients with renal osteopathy complicated by nephrotic syndrome. (4) Patients with bone marrow disease and leukemia. (5) Those who take glucocorticoids and anti-osteoporosis drugs. (6) Pregnancy or preparation for pregnancy, lactating women.

Design outcomes

Primary

Measure	Time frame
miRNA-25;	—

Countries

China

Contacts

Public ContactHu Wen

Huai'an Second People's Hospital

Huwen787878@163.com+86 15189658236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026